Cargando…

Impact of Cytochrome Induction or Inhibition on the Plasma and Brain Kinetics of [(11)C]metoclopramide, a PET Probe for P-Glycoprotein Function at the Blood-Brain Barrier

[(11)C]metoclopramide PET imaging provides a sensitive and translational tool to explore P-glycoprotein (P-gp) function at the blood-brain barrier (BBB). Patients with neurological diseases are often treated with cytochrome (CYP) modulators which may impact the plasma and brain kinetics of [(11)C]me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Breuil, Louise, Ziani, Nora, Leterrier, Sarah, Hugon, Gaëlle, Caillé, Fabien, Bouilleret, Viviane, Truillet, Charles, Goislard, Maud, El Biali, Myriam, Bauer, Martin, Langer, Oliver, Goutal, Sébastien, Tournier, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785688/ https://www.ncbi.nlm.nih.gov/pubmed/36559144 http://dx.doi.org/10.3390/pharmaceutics14122650

Ejemplares similares

Comparison of the Blood–Brain Barrier Transport and Vulnerability to P-Glycoprotein-Mediated Drug–Drug Interaction of Domperidone versus Metoclopramide Assessed Using In Vitro Assay and PET Imaging
por: Breuil, Louise, et al.
Publicado: (2022)

Validation of a pharmacological imaging challenge using (11)C-buprenorphine and (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography to study the effects of buprenorphine to the rat brain
por: Soyer, Amélie, et al.
Publicado: (2023)

Pharmacokinetic Imaging Using (99m)Tc-Mebrofenin to Untangle the Pattern of Hepatocyte Transporter Disruptions Induced by Endotoxemia in Rats
por: Marie, Solène, et al.
Publicado: (2022)

Positron Emission Tomography Imaging Reveals an Importance of Saturable Liver Uptake Transport for the Pharmacokinetics of Metoclopramide
por: Caillé, Fabien, et al.
Publicado: (2018)

Impact of Donepezil on Brain Glucose Metabolism Assessed Using [(18)F]2-Fluoro-2-deoxy-D-Glucose Positron Emission Tomography Imaging in a Mouse Model of Alzheimer’s Disease Induced by Intracerebroventricular Injection of Amyloid-Beta Peptide
por: Hugon, Gaëlle, et al.
Publicado: (2022)

[(18)F]2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood-Brain Barrier Permeability Induced by Focused Ultrasound
por: Hugon, Gaëlle, et al.
Publicado: (2021)

Isotopic Radiolabeling of the Antiretroviral Drug [(18)F]Dolutegravir for Pharmacokinetic PET Imaging
por: Tisseraud, Marion, et al.
Publicado: (2022)

Isotopic Radiolabeling of Crizotinib with Fluorine-18 for In Vivo Pet Imaging
por: Sardana, Malvika, et al.
Publicado: (2022)

Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice
por: Biali, Myriam El, et al.
Publicado: (2023)

Impaired Clearance From the Brain Increases the Brain Exposure to Metoclopramide in Elderly Subjects
por: Bauer, Martin, et al.
Publicado: (2020)

Human Biodistribution and Radiation Dosimetry of the P-Glycoprotein Radiotracer [(11)C]Metoclopramide
por: Bauer, Martin, et al.
Publicado: (2021)

Impact of rifampicin-inhibitable transport on the liver distribution and tissue kinetics of erlotinib assessed with PET imaging in rats
por: Amor, Dorra, et al.
Publicado: (2018)

Acute Morphine Exposure Increases the Brain Distribution of [(18)F]DPA-714, a PET Biomarker of Glial Activation in Nonhuman Primates
por: Auvity, Sylvain, et al.
Publicado: (2016)

Trial of Oral Metoclopramide on Diurnal Bruxism of Brain Injury
por: Yi, Ho Sung, et al.
Publicado: (2013)

Imaging-Based Characterization of a Slco2b1((-/-)) Mouse Model Using [(11)C]Erlotinib and [(99m)Tc]Mebrofenin as Probe Substrates
por: Marie, Solène, et al.
Publicado: (2021)

Imaging P‐Glycoprotein Function at the Blood–Brain Barrier as a Determinant of the Variability in Response to Central Nervous System Drugs
por: Bauer, Martin, et al.
Publicado: (2019)

Influence of Cation Transporters (OCTs and MATEs) on the Renal and Hepatobiliary Disposition of [(11)C]Metoclopramide in Mice
por: Hernández-Lozano, Irene, et al.
Publicado: (2021)

Validation of Pharmacological Protocols for Targeted Inhibition of Canalicular MRP2 Activity in Hepatocytes Using [(99m)Tc]mebrofenin Imaging in Rats
por: Marie, Solène, et al.
Publicado: (2020)

METOCLOPRAMIDE IN TARDIVE DYSKINESIA
por: Hemanani, T.J., et al.
Publicado: (1983)

Metoclopramide-induced akathisia
por: Chauhan, Gaurav, et al.
Publicado: (2012)

TSPO PET Imaging as a Potent Non-Invasive Biomarker for Diffuse Intrinsic Pontine Glioma in a Patient-Derived Orthotopic Rat Model
por: Chevaleyre, Céline, et al.
Publicado: (2022)

ABCB1 and ABCG2 Together Limit the Distribution of ABCB1/ABCG2 Substrates to the Human Retina and the ABCG2 Single Nucleotide Polymorphism Q141K (c.421C> A) May Lead to Increased Drug Exposure
por: El Biali, Myriam, et al.
Publicado: (2021)

Pitfalls and solutions of the fully-automated radiosynthesis of [(11)C]metoclopramide
por: Pichler, Verena, et al.
Publicado: (2019)

Dystonic reactions to metoclopramide (maxolon).
por: Reid, M.
Publicado: (1977)

Metoclopramide-induced cardiac arrest
por: Rumore, Martha M., et al.
Publicado: (2011)

Metoclopramide-induced Serotonin Syndrome
por: Harada, Taku, et al.
Publicado: (2017)

Metoclopramide-induced Serotonin Syndrome
por: Meegada, Sreenath, et al.
Publicado: (2019)

Does Metoclopramide Reduce Variceal Pressure?
por: Spence, R. A. J.
Publicado: (1992)

Pharmacokinetics of metoclopramide in calves with renal dysfunction
por: TAKAYASU, Mariko, et al.
Publicado: (2014)

Efficacy of metoclopramide for the treatment of acute migraine
por: Jiang, Chao, et al.
Publicado: (2019)

Comparative test-retest variability of outcome parameters derived from brain [(18)F]FDG PET studies in non-human primates
por: Goutal, Sébastien, et al.
Publicado: (2020)

Longitudinal mouse-PET imaging: a reliable method for estimating binding parameters without a reference region or blood sampling
por: Wimberley, Catriona, et al.
Publicado: (2020)

Case report: Pallidal deep brain stimulation for treatment of tardive dystonia/dyskinesia secondary to chronic metoclopramide medication
por: Nagel, Johanna M., et al.
Publicado: (2023)

Decreased blood-brain barrier P-glycoprotein function with aging
por: Bauer, Martin, et al.
Publicado: (2008)

PEGylated Tween 80-functionalized chitosan-lipidic nano-vesicular hybrids for heightening nose-to-brain delivery and bioavailability of metoclopramide
por: Al-Zuhairy, Saeed A. S., et al.
Publicado: (2023)

Metoclopramide protection of diazinon-induced toxicosis in chickens
por: Al-Zubaidy, M. H. I., et al.
Publicado: (2007)

Does metoclopramide prevent bacterial translocation (BT)?
por: Cansizoglu, F, et al.
Publicado: (2000)

Severe akathisia as a side effect of metoclopramide
por: Van Gool, Arthur R., et al.
Publicado: (2010)

Oculogyric crisis in a patient taking metoclopramide
por: Koban, Yaran, et al.
Publicado: (2014)

Erythromycin or metoclopramide for feed intolerance in the critically ill
por: Nguyen, N, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_rilki033nms2lmpaa7fos7c9su